Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-32.21	102.52	151.24
Graham Fair Price	3.77	14156.23	13641.76
PEG	10788.56	33.94	0.31
Price/Book	-9.11	8.20	9.02
Price/Cash Flow	769.95	639.92	73.56
Prices/Earnings	-4.29	38.11	39.82
Price/Sales	-11.57	9.81	11.09
Price/FCF	769.95	639.92	73.56
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	13.89	0.14	0.12
Operating Margin	17.15	0.11	0.10
ROA	-5.50	0.02	0.02
ROE	0.06	0.05	-5.04
ROIC	0.03	0.03	19.68
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.00	-1.00	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.95	0.28	-70.40
EPS QOQ	1.28	0.01	-99.12
FCF QOQ	0.00	-0.89	-100.00
Revenue QOQ	0.03	0.09	212.74
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	66.42	100.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	1.35	100.00
Debt/Capitalization	0.00	0.48	100.00
Quick Ratio	0.00	0.10	100.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	12086.57	12870.86	6.49
Cash	0.00	885.67	100.00
Capex	-104.86	-93.68	10.66
Free Cash Flow	1481.83	164.86	-88.87
Revenue	9827.75	10757.16	9.46
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.46	1.47	0.83
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.00	9.61	100.00
Naive Interpretation	Member

06 - Financial Health · Weak

Rating